The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
ONLY
ARTICLE
June 18, 2018
A New Amphetamine Oral Suspension (Adzenys ER) for ADHD (online only)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
A New Amphetamine Oral Suspension (Adzenys ER) for ADHD (online only)
June 18, 2018 (Issue: 1549)
The FDA has approved an extended-release oral
suspension formulation of amphetamine (Adzenys ER
– Neos) for treatment of attention deficit hyperactivity
disorder (ADHD) in patients ≥6 years old. The same
extended-release amphetamine product...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.